Skip to main content
Ernesto Bernal-Mizrachi, MD, Endocrinology, Coral Gables, FL

Ernesto Bernal-Mizrachi MD

Adrenal Disease, Diabetes, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology


Chief, Division of Endocrinology, Diabetes and Metabolism, University of Miami Miller School of Medicine

Join to View Full Profile
  • 5555 Ponce de Leon BlvdCoral Gables, FL 33146

  • Phone+1 305-689-3636

  • Fax+1 305-243-6575

Dr. Bernal-Mizrachi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1999
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Internal Medicine, 1993 - 1996
  • Universidad del Valle Health Sciences
    Universidad del Valle Health SciencesClass of 1989

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2016 - 2026
  • MI State Medical License
    MI State Medical License 2009 - 2019
  • MO State Medical License
    MO State Medical License 1999 - 2010
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2010

Publications & Presentations

PubMed

Lectures

  • Androgen Excess in Pancreatic Β Cells and Neurons Predisposes Female Mice to Type 2 Diabetes 
    Ann Arbor, MI - 6/14/2014

Press Mentions

  • Research Illuminates Potential Pathway to Type 2 Diabetes
    Research Illuminates Potential Pathway to Type 2 DiabetesSeptember 21st, 2017
  • Enzyme Protects Insulin-Producing Cells Against Chronic High Glucose
    Enzyme Protects Insulin-Producing Cells Against Chronic High GlucoseJanuary 12th, 2016

Grant Support

  • Loss of insulin signaling across functional pancreas compartments as a major pathogenic mechanism underlying diabetic exocrine pancreatopathyUNIVERSITY OF MIAMI SCHOOL OF MEDICINE2024–2028
  • Loss of insulin signaling across functional pancreas compartments as a major pathogenic mechanism underlying diabetic exocrine pancreatopathyUNIVERSITY OF MIAMI SCHOOL OF MEDICINE2024–2028
  • mTOR signaling and regulation of alpha-cell mass and functionMIAMI VA HEALTH CARE SYSTEM2016–2028
  • mTOR signaling and regulation of alpha-cell mass and functionMIAMI VA HEALTH CARE SYSTEM2016–2028
  • mTOR signaling and regulation of alpha-cell mass and functionMIAMI VA HEALTH CARE SYSTEM2016–2028
  • mTOR signaling and regulation of alpha-cell mass and functionMIAMI VA HEALTH CARE SYSTEM2016–2028
  • mTOR signaling and regulation of alpha-cell mass and functionMIAMI VA HEALTH CARE SYSTEM2016–2028
  • Amino acid sensing mechanisms in beta and alpha cellsUNIVERSITY OF MIAMI SCHOOL OF MEDICINE2022–2027
  • Role of mTORC1 signaling in type 1 diabetesUNIVERSITY OF MIAMI SCHOOL OF MEDICINE2022–2026
  • Nutrient Signals And Programming Of Pancreas DevelopmentNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • Akt/Mtor Signaling And Regulation Of Cell Cycle In Beta CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
  • Akt/Mtor Signaling And Regulation Of Cell Cycle In Beta CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2009
  • Regulation Of Pancreas Development By P13k/Akt SignalingNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2006

Professional Memberships

Other Languages

  • Spanish

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: